NCT04352959View on ClinicalTrials.gov

COVID-19: Nasal and Salivary Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses

NACompletedINTERVENTIONAL
Enrollment

176

Participants

Timeline

Start Date

April 27, 2020

Primary Completion Date

December 11, 2020

Study Completion Date

December 11, 2020

Conditions
COVID19MouthwashSaliva
Interventions
DEVICE

mouthrinse with bêta-cyclodextrin and citrox

3 daily mouthrinses for 7 days

DEVICE

mouthrinse without bêta-cyclodextrin and citrox

3 daily mouthrinses for 7 days

Trial Locations (4)

40000

Intercommunal Hospital Center of Mont de Marsan, Mont-de-Marsan

43000

Hospital Center Emile Roux, Le Puy-en-Velay

69007

Hospital Center Saint Luc Saint Joseph, Lyon

69300

Clinic of the Protestant Infirmary in Lyon, Caluire-et-Cuire

All Listed Sponsors
collaborator

Hospices Civils de Lyon

OTHER

lead

Claude Bernard University

OTHER

NCT04352959 - COVID-19: Nasal and Salivary Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses | Biotech Hunter | Biotech Hunter